Radiopharmaceuticals for WBAMC
Contract Opportunity Analysis
The Department of Defense, specifically the Department of the Army, is soliciting proposals from Women-Owned Small Businesses (WOSB) to supply radiopharmaceuticals to the Nuclear Medicine Section at William Beaumont Army Medical Center (WBAMC) located in Fort Bliss, Texas. The procurement requires the delivery of specific radiopharmaceuticals, including DAT Scan Ioflupane 123, Indium Oxine, Ceretec kit, Adreview, and MPI Indium DTPA IN 111, with a deadline for delivery set for October 1, 2025. These pharmaceuticals are critical for medical imaging and diagnostics, adhering to U.S. Pharmacopeia <825> guidelines and Joint Commission accreditation standards. Proposals are due by September 9, 2025, and will be evaluated using the Lowest Price, Technically Acceptable (LPTA) method, with key clauses related to Item Unique Identification and Wide Area WorkFlow payment instructions. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Timothy T. Hoerz at timothy.t.hoerz.civ@mail.mil for further information.